DatasetName,KIF21A_S(1176) KIF21A_S(1190) KIF21A_S(1199) KIF21A_S(1203) KIF21A_S(1209) KIF21A_S(1212) KIF21A_S(1223) KIF21A_S(1225) KIF21A_S(1226) KIF21A_S(1228) KIF21A_S(1229) KIF21A_S(1231) KIF21A_S(1233) KIF21A_S(1235) KIF21A_S(1239) KIF21A_S(1249) KIF21A_S(1271) KIF21A_S(1275) KIF21A_S(1293) KIF21A_S(1298) KIF21A_S(1304) KIF21A_S(1307) KIF21A_S(1662) KIF21A_S(1673) KIF21A_S(518) KIF21A_S(520) KIF21A_S(524) KIF21A_S(571) KIF21A_S(587) KIF21A_S(6) KIF21A_S(705) KIF21A_S(710) KIF21A_S(8) KIF21A_S(853) KIF21A_S(855) KIF21A_S(9) KIF21A_T(1229) KIF21A_T(1242) KIF21A_T(1664) KIF21A_T(579) KIF21A_T(581) KIF21A_Y(186),KIF21A_S(1310) KIF21A_S(857) KIF21A_T(1265)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.49848428557331054,
FSO2013_Ratio M/L normalized Rep3,0.4909945302233916,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5171978121843172,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.49696971776689564,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.5054127754707353,
ZX2022_Control Replicate 2,0.49382976228099407,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5096913253273101,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.49655854551004064,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4978829345672073,
DB2022_Intensity L2,0.5019820657642095,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.4959171263592795,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.49734187481648234,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5159257057815299,
WZ2023_Pu_010_30min,0.504263684329014,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.4970751384574428,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5014766285845706,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.4964734623443079,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.49674100249586023,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.4981779534561658,
PG2020_Intensity 8h_C,0.48739283510026654,
AH2018_SILAC_MR_2_N,0.5011624458328771,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.49640990332787843,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.4982173689914604,
FSO2013_Ratio H/L normalized Rep2___2,0.4997605323492503,
EP2017_Pervanadate R#3 normalized log2 ratio,0.49767012249414383,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.5000530188109815,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5022302624253248,
GF2025_P6_Sph,0.4914320888207319,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.49468060341616243,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5037009871336797,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.4959168299617614,
WZ2023_Pu_005_10min,0.5039895029808177,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.4839368671605721,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.49447760490646964,
WZ2023_Pu_025_30min,0.5043621279132513,
AH2018_SILAC_MR_2_X,0.5017593410345861,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.49678518430955926,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.4973091597191341,
EJN2021_3_Rest_Basal,0.49530354436622914,
CR2017_Ratio Replicate 1.3,0.4942962803992327,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.4979102454576364,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5009715445963571,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5014886535016485,
AH2018_LFQ_1_C,0.5026158886677027,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.503089515186779,
CK2022_11 40-1,0.4796384271241669,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.4994543915151387,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5160417432468151,
FSO2013_Ratio H/L normalized Rep2,0.49560374348399056,
WZ2023_Pu_005_20min,0.5039719969286236,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.49794085359041773,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5046740215311113,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.5000885259585731,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.4923761611410003,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,0.49821966650020416,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.482226499673092,
CK2022_1 200-1,0.5123691122287684,
PG2020_Intensity Mock_10h_D,0.489510864886971,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4997632070073484,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.507594529313294,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.495735185322759,
PG2020_Intensity 2h_C,0.4855878183957015,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.4937947751635563,
KBE2022_Log2_Ex_8_T,0.4966912704878964,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.4995691099802924,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5035735088050612,
CK2022_3 40-1,0.48611182336579617,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.49644261912076476,
HH2022_Reporter intensity 8,0.4983382664550701,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5019831672434544,
EJN2021_5_Rest_Basal,0.4941663719089484,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5000900368767749,
YA2020_Reporter_intensity_Normal_No.1,0.49479647397846654,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.4960522903402539,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.501040721236482,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.49547692829832063,
HS2024_8_I_T3,,
CF2017_EOC 3,0.4990859513649363,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.5024645022581078,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5041058699901353,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.4856654055449032,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5162433991002102,
KS2014_Intensity N3,0.5118034782261673,
RB2022_4_RecoveryEndurance,0.500181875435028,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.4976159881846848,
FSO2013_Ratio H/M normalized Rep2,0.4952626216242745,
RAM2015_Log2 A,0.5002289468654103,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.49996223654544647,
KS2014_Intensity E15_2,0.5174775847702803,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.4927796272354491,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.4948294145055455,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.4986395509876052,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5005635720258813,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5157093393941594,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.49852299457267657,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5000824655811581,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.49561097453625486,
FSO2013_Ratio M/L normalized Rep2,0.5081386873548718,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.4986360119970092,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.4777803140517532,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.4917068297192493,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.4998064188507934,
DL2023_control-1,0.5056240745256853,
AR2021_ALG 10 μM,0.500538022501811,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5003925619822059,
EJN2021_4_Rest_Ins,0.4934546291338111,
RN2012_H05,0.4962021168681579,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.49951527488992575,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.49398166532081333,
HH2022_Reporter intensity 3,0.49880372329033706,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.4995364849132844,
JW2021_After_3,,
GF2025_P8_Sph,0.49388260090128755,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.49923753403839444,
CK2022_11 200-1,0.5054836196102748,
CK2022_12 200-1,0.5050528406739521,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5011805887066434,
WZ2023_Su_010_20min,0.5032649044895136,
AH2018_TMTMS2_2_N,0.49950925457029394,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.49581479755204655,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5010670030743739,
AH2018_TMTMS3_Pool,0.4991991567703889,
KS2014_Intensity N4,0.5051002030470266,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.49744850083617675,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.4997099798470404,
CK2022_14 200-1,0.5071420422643138,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4931066866261981,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4937701533520455,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.49459038806402844,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.4739798098965848,
GF2025_P1_Adh,0.49646757567083305,
GF2025_P1_Sph,0.49583351710420265,
EJN2021_5_Ex_Basal,0.4882622119783144,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5036227192551748,
CF2017_EOC 1,0.4981518463528785,
CK2022_3 200-1,0.5132434776737684,
AH2018_LFQ_IT_3_C,0.49927926204511486,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.500109744984038,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5066578836470907,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.4843472507338036,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5141770830631408,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5167210552820024,
AR2021_ALG 1 μM,0.5028691960010646,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.49478193230497697,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5089142793714375,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.501002251084655,
CK2022_9 16-1,0.4744048939404332,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.4966909241175198,
CK2022_13 200-1,0.5068435644143623,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.49341178792926726,
CK2022_16 16-1,0.47353230445915984,
FS2019_db/db3,,
CK2022_15 40-1,0.47764433640647413,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.502445751381164,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.49673208903477584,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.4994082008647281,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5027260867359774,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.4957845281997522,
AH2018_LFQ_M_1_N,0.5044685461725567,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.49475044792088463,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5002225823889689,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.48819220290616583,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.47794269179463783,
RN2012_L13,0.4993362940963733,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.49733012304243507,
SR2019_SKBR3_Biol_repl_3,0.5000324677024683,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5002891455403132,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4839288193378899,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.511469698789462,
HH2022_Reporter intensity 6,0.49847988367686197,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,0.4958111141317258,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4898163161082652,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.5001615486974254,
AH2018_TMTMS2_3_X,0.5008921331181918,
GF2025_P3_Adh,0.5017303995867392,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.4936001989069182,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.4876908207073219,
KBE2022_Log2_Ex_19_U,0.49544022315669217,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.4960533650803609,
YA2020_Reporter_intensity_Cancer_No.1,0.5003836329778748,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4968557758637615,
LG2023_Control-2_intensity,0.4961044997403271,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,0.4952361742093982,
RB2022_5_RecoverySprint,0.4985567056441384,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5016900626933746,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.501320672746041,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5044220688219835,
HH2022_Reporter intensity 1,0.4987682289721784,
HH2022_Reporter intensity 2,0.4988621930174149,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4973505416779993,
SR2019_MCF7_Biol_repl_1,0.4968062385560834,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.4943166132593647,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.49609058561863717,
CR2017_Ratio Replicate 2,0.48838319001561475,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4962433874602053,
AR2021_KD 72h,0.49831966658092586,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4985621020594055,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.5006314548073281,
KBE2022_Log2_Ex_13_T,0.4955351208954229,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.4996271355500275,
PG2020_Intensity Mock_10h_C,0.4759994900595868,
CF2017_OSE 29,0.4992616651543954,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5033767182384308,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5006636529770632,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.49881263494631106,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5014748180944403,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.504781540020485,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.4906270065291616,
TM2022_S2.12h.B,,
RN2012_L15,0.4953440529188638,
KS2014_Intensity pY_PV3,0.4948161672161344,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.4905403829038933,
FSO2013_Ratio H/M normalized Rep2___2,0.4957765474884673,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4975592969081195,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5268924105049848,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5507940301582298,
CK2022_5 200-1,0.5495266636785173,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.4949305596400866,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.502048389240449,
AH2018_SILAC_MR_1_X,0.5009397848442784,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.4979506035290902,
AH2018_SILAC_3_C,0.49882573366870125,
EJN2021_5_Rest_Ins,0.49408566210545163,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,0.49820688031111304,
FSO2013_Ratio H/M normalized Rep1,0.4938408768980023,
CK2022_4 16-1,0.4849070566212731,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.49811011719645654,
EJN2021_2_Ex_Ins,0.4956787832924035,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5003223336735633,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.49735054916174515,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.4914868329611905,
FSO2013_Ratio H/L normalized Rep3,0.5019369572861013,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.4987300203578926,
AH2018_SILAC_IT_1_X,0.5000654077717166,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.4980263864448161,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.49474696004080265,
WZ2023_Pe_025_20min,0.504456410580628,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5019220460037697,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5021117082203017,
RN2012_H06,0.5044255364634099,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5034843945926081,
SR2019_HCC1419_Biol_repl_4,0.500132004977288,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.49808759778392847,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5141565739190197,
WZ2023_Su_025_10min,0.5030723711360422,
AH2018_LFQ_IT_4_X,0.4979077210268306,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.49894763467501657,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5031481238155134,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.49539544795428064,
EP2017_Pervanadate R#1 log2 ratio,0.5039480371968993,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.539727588301645,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.49477024150825855,
LY2019_P7+,0.5039317172775479,
EP2017_Untreated R#1 normalized log2 ratio,0.4973271778175262,
RN2012_L10,0.49586184538787603,
PG2020_Intensity 4h_C,0.49445462960051706,
EP2017_Mitotic R#3 normalized log2 ratio,0.5033209360206574,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,0.49743904785789955,
KBE2022_Log2_Ex_24_T,0.49696733451416214,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5001953295561888,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.4886271121813409,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5058280088158076,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4920866150633938,
GF2025_P9_Sph,0.4944896929847807,
CK2022_6 200-1,0.5497238636690256,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.49412606268822074,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,0.49473123937896396,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.4989538480663698,
PG2020_Intensity 2h_D,0.4888181323741705,
EP2017_Untreated R#3 normalized log2 ratio,0.48987664867065644,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5492677926743633,
KS2014_Intensity pY_C4,0.49762212609223144,
CR2017_Ratio Replicate 3.5,0.498910150228055,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.498485548346734,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,0.4966901076728011,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.4993122478040348,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.4914209760968075,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5016787781346856,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.49873713599872893,
PG2020_Intensity CT_C,0.4919869201600643,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,0.4992807300230697,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.48975569852768064,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4999697591381935,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.4990586614321015,
CR2017_Ratio Replicate 2.3,0.5062782070886009,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.49714206774224173,
YA2020_Reporter_intensity_Normal_No.2,0.496058765372737,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4981757381639915,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5040539133657277,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4958727319617743,
CK2022_2 16-1,0.4822824954441777,
RAM2015_Log2 B,0.5001671066296465,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5133965275703345,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.4945559328817479,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.49792241494227224,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,0.5004756222437378,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.49625263165832045,
WZ2023_Su_025_30min,0.5032614220681226,
AH2018_LFQ_4_N,0.49879477665865146,
CR2017_Ratio Replicate 1.2,0.49064172253695,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.49829845608603546,
AH2018_SILAC_M_1_X,0.4930787046564356,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.5065526921291843,
LY2019_P6+,0.5045770588394303,
DB2022_LFQ intensity R2,0.501608271732009,
GF2025_P6_Adh,0.49638896228376683,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4986673011651061,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5303083479023988,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.4985073240828585,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.49873426466615717,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5045744130288101,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4878908089033299,
AH2018_LFQ_2_X,0.5014489736058876,
PG2020_Intensity 2h_B,0.4903611755075625,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.4994602201888518,
KS2014_Intensity E15_3,0.5220636290849259,
GF2025_P3_Sph,0.4989097774925586,
DB2022_LFQ intensity L2,0.49822861647241357,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.4969650084259889,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5124336370758217,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4986656587847657,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.49822301541670105,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.49973523910526957,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.49467209315813687,
ZQ2022_N1,,
LY2019_P6-,0.5022428778052149,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.4981688532616718,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4992809018777892,
AH2018_LFQ_3_N,0.504664093065549,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.49794124639166865,
KBE2022_Log2_Ex_13_U,0.4960992374888849,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5055530412385343,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.49198730899581716,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5028924805469822,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.49556044907250607,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.4955494446749661,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.4778802056686612,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.49374629949923543,
PG2020_Intensity 10h_D,0.4943915627001791,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.4947808284848527,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.49590129187980303,
EP2017_Pervanadate R#3 log2 ratio,0.4981090913702391,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5005340130204153,
AH2018_LFQ_M_4_C,0.5021648745036797,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.5058789552419538,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,0.49703943953285695,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5030961274219925,
CK2022_6 40-1,0.506226496505275,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5044767548109486,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.4960163872908574,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5038045614845378,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.4910542939662679,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4942315220549775,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5037191409834375,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.4976125673315434,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.49704155117844084,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5044585574007898,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.4971282586979544,
LY2019_P8+,0.5063239252417124,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.494608942074994,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.498072277283099,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.4994657084430568,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5019306264341497,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.4975920048907016,
LY2019_P2-,0.49845211742858087,
AH2018_LFQ_IT_1_X,0.4973983582933436,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5037305963777984,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.48669160485865165,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,0.4962635968458597,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.49888576506191495,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5022579117654827,
SR2019_HCC1419_Biol_repl_2,0.4997674077943242,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5011025410751182,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.502929035121343,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5040744105886502,
KS2014_Intensity C2,0.5305514828194349,
FSO2013_Ratio H/L normalized Rep1___2,0.4937971242122509,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5116751260118784,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,0.4949636220154347,
CK2022_10 200-1,0.5122988110494229,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.48785979172456484,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4989731413822159,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5074597695935049,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.4942645324701636,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,0.49890234214136653,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.49723969059743967,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5040229585559738,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5003357478700317,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5057952546136087,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4914018245006015,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5013369802325004,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.4892372067815338,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5009640792506566,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.49893998927598304,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.4959700070064598,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.500479093056376,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5030916277828129,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5038234959873976,
AH2018_LFQ_IT_4_N,0.5000768977177289,
CK2022_15 200-1,0.5065837085696467,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.4966893902345336,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5062810741202184,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5130160712906167,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5032697271025199,
RN2012_H01,0.5007076698673545,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.4936142169964498,
KS2014_Intensity pY_E5_3,0.49740390278919494,
MM2018_Ratio H/L replicate 3,0.4988331723764338,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5035892929452012,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.4963551910245338,
KBE2022_Log2_Ex_44_U,0.4973775206666418,
WZ2023_Pe_010_20min,0.5034732096643663,
KS2014_Intensity pY_C6,0.4964747989332786,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.4968520292868133,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5266365333051406,
FSO2013_Ratio H/M normalized Rep3___1,0.494206610709597,
AH2018_SILAC_M_3_C,0.4994956304247277,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5004404276399859,
AH2018_SILAC_M_2_X,0.5002840811492903,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5027296563036218,
PG2020_Intensity 6h_C,0.4874559651274864,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5083421404676511,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5004046420906071,
CK2022_15 16-1,0.47571910530196054,
CK2022_3 16-1,0.48322133476979895,
LY2019_P4-,0.49007365977050943,
FSO2013_Ratio H/L normalized Rep3___2,0.5071478835282229,
KS2014_Intensity pY_PV2,0.495521760332654,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.4957576588066575,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.49565411553193556,
CK2022_10 16-1,0.4790610601740183,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4969343003894565,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,0.5003459383545332,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.49802193212358037,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,0.49893276573732287,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4913588832058824,
EJN2021_2_Ex_Basal,0.4930240946405006,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5002873831733902,
AR2021_L41 10 μM,0.5003033984519065,
CF2017_EOC 2,0.49780286288642517,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.49762398232024,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.49824479642713726,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5160479325663427,
ZX2022_CB treated Replicate 1,0.4884401939465487,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4990128452742428,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.49553479653452875,
AR2021_L41 1 μM,0.49558650777502755,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4973974207390861,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.4932096122993065,
KS2014_Intensity C4,0.5215816088705105,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5019287170863536,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.49226590307457796,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.499296169409533,
WZ2023_Pu_025_10min,0.5049578498781264,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.4984176751626889,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.4984893173318931,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5034110386546088,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.49919813788319656,
KS2014_Intensity C6,0.5212678763508125,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.482780418058857,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4946530976801372,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.4780461030722012,
AH2018_SILAC_IT_2_C,0.49917395427819855,
CK2022_5 40-1,0.505604543293657,
AH2018_LFQ_3_X,0.5028850322930138,
UK2020_UA_3,0.49783512494458715,
LY2019_P7-,0.5023944821156486,
GF2025_P5_Adh,0.4999298136855798,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.49415580285431016,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.497643982498927,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.4711754709196478,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.49401887548275186,
PG2020_Intensity CT_B,0.4841752204551938,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5014975031996911,
KS2014_Intensity pY_E5_1,0.49725173682319823,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5020497259608696,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5072935045260983,
YA2020_Reporter_intensity_Cancer_No.4,0.49522328255429116,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.49757263547579034,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.49745507652085585,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.4713383354493128,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.4993928884612532,
KS2014_Intensity pY_N1,0.4953983488979243,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.4926665649093918,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4989001682904411,
AH2018_TMTMS2_1_X,0.497871314100513,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.4946399171835556,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.4976500756092779,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.4974086362559364,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.4958052833821053,
CF2017_FTE 14,0.498369477901842,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4935943428180695,
SR2019_HCC1419_Biol_repl_3,0.5006010129034065,
KBE2022_Log2_Ex_14_T,0.4978097263938374,
EP2017_Untreated R#2 normalized log2 ratio,0.4944250682637959,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,0.5012672134319595,
LY2019_P5+,0.4879703241903678,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.49902876722305917,
AS2011_Ratio H/L Normalized RNAi_2_1,,
